Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
Canada
/
Pharmaceuticals & Biotech
Create a narrative
Cronos Group Community
TSX:CRON Community
1
Narratives
written by author
0
Comments
on narratives written by author
12
Fair Values set
on narratives written by author
Create a narrative
Cronos Group
Latest
Undervalued
Overvalued
Community Investing Ideas
Cronos Group
AN
AnalystConsensusTarget
Consensus Narrative from 5 Analysts
Global Cannabis Expansion Will Thrive Amid Tariff Challenges
Key Takeaways Growing international presence and facility expansions position Cronos for increased revenue, reduced regional dependency, and improved operating leverage. Focus on innovative wellness products and disciplined financial management supports sustained margin improvement and long-term growth flexibility.
View narrative
CA$3.48
FV
25.7% undervalued
intrinsic discount
11.10%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
9
users have followed this narrative
7 days ago
author updated this narrative
Your Valuation for
CRON
CRON
Cronos Group
Your Fair Value
CA$
Current Price
CA$2.59
12.5% undervalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
-310m
929m
2015
2018
2021
2024
2025
2027
2030
Revenue US$198.3m
Earnings US$78.7m
Advanced
Set Fair Value